InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by HOLMLUND JON T, Directeur Médical. Director active across 1 companies, notably Galera Therapeutics, Inc.. In total, 2 reports have been published. The latest transaction was disclosed on 1 September 2021 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
€98,00547,756 shares@ €2.0522100.0% of flow
Common Stock
SEC:0000899243-21-035130·
€98,00547,756 shares@ €2.05220.61% mcap50.0% of flow
Common Stock
SEC:0000899243-21-035130:0·
2 of 2 declarations
About HOLMLUND JON T
Jon T. Holmlund is the Chief Medical Officer at Galera Therapeutics, Inc. In this role, he is responsible for leading the company's clinical initiatives and medical strategy. With extensive expertise in the medical and pharmaceutical fields, he plays a key role in the development of innovative treatments and overseeing clinical trials. His experience contributes to Galera's commitment to improving patient outcomes.
